🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this interventional study is to determine whether neflamapim...
Status
Active Not Recruiting
Location
Campbelltown Hospital
Start Date
2025-06-20
Trial ID
NCT06987643
Treatments Being Tested
This study will assess the effects of administration of VX-745 for 12 weeks...
Status
Completed
Location
Alzheimer Research Center, VU Medical Center
Start Date
2015-04
Trial ID
NCT02423122
Treatments Being Tested
This is a phase 2b, double-blind, placebo controlled proof-of-concept study...
Status
Completed
Location
Alliance for Research
Start Date
2017-12-29
Trial ID
NCT03402659
Treatments Being Tested
This is a double-blind, placebo-controlled 2-period 10-week treatment withi...
Status
Terminated
Location
John Van Geest Centre for Brain Repair
Start Date
2019-07-08
Trial ID
NCT03980938
Treatments Being Tested
The purpose of this clinical study is to evaluate the safety and tolerabili...
Status
Completed
Location
Hôpital Lariboisière - APHP; Centre de Neurologie Cognitive
Start Date
2024-10-16
Trial ID
NCT06815965
Treatments Being Tested
For this project, neflamapimod and placebo will be provided free of charge ...
Status
Completed
Location
CHU Toulouse
Start Date
2018-10-08
Trial ID
NCT03435861
The purpose of this study is to determine whether neflamapimod can improve ...
Status
Completed
Location
Barrow Neurological Institute
Start Date
2023-05-01
Trial ID
NCT05869669
Treatments Being Tested
This study will assess the effects of VX-745 on markers of disease in the c...
Status
Completed
Location
Parexel International
Start Date
2015-04
Trial ID
NCT02423200
Treatments Being Tested